Other · developed by PFIZER
PF-08046033 is a powder for solution for infusion. It is studied in non-small-cell lung cancer, esophageal cancer and cutaneous melanoma.
Summary written with AI from the sources listed at the end of this page.
Cutaneous MelanomaEsophageal CancerNon-Small-Cell Lung
Updated Nov 8, 2026. Something wrong or missing? Report it on the PFE page.
See PFE's upcoming FDA decisions, trial readouts, cash runway and dilution risk, updated every day from SEC, FDA and ClinicalTrials.gov filings.
PFE catalysts and pipeline →